Dr. Abud Bakri

It's like these 21 amino acids.

It increases T-cell development in the thymus, increases T-cell proliferation outside the thymus, and makes the T-cells more likely to properly attack a pathogen.

It's like a jet fuel for the T-cells.

So it's like pro-immune.

peptide Wild West kind of indications.

It was FDA approved as Zidaxin for kids that were born without a thymus or a malfunction thymus like DeGeorge syndrome, these different kind of genetic abnormalities to be used for these kids to help develop the T cells that they had that weren't in the thymus because they'd have like bone marrow T cells that weren't properly developed.

So there was good support from thymus enough one for these kids.

I don't think that FDA approval still exists.

So the people are trying to, you know, grandfather Thymus and Alpha-1 into this peptide conversation.

In other countries, it's approved for a adjuvant therapy for like hepatitis B, hepatitis C, and then different cancers.

So far, the sepsis literature and the infectious literature is not that promising.

It might be like...

If you take antibiotics with thymus and alpha-1, you might have a quicker bounce around.

What I would be interested to see is like if you went to nursing homes, injected everybody with thymus and alpha-1 in November, in December, would you have less flu in January and February?

That'd be the interesting thought experiment.

Both thymus and alpha-1 and thymus and beta-4 come out of the Goldstein lab.

That's a very famous lab that studied thymus in the 70s, 80s, and 90s.

But thymic research kind of fell out of favor the last few decades.

Oh, yeah.

I've used thymus alpha-1 when I travel to avoid the...